Drugs in pregnancy. Gastrointestinal disease.
Gastrointestinal diseases in pregnancy can be divided into diseases specific to pregnancy, for example, hyperemesis gravidarum, obstetric cholestasis, HELLP syndrome and acute fatty liver of pregnancy, and diseases incidental to pregnancy, for example, inflammatory bowel disease, dyspepsia, peptic ulcer disease and viral hepatitis. Disorders in the second category may present for the first time in pregnancy. This chapter considers the drug management of each of these conditions, with the exception of HELLP syndrome and acute fatty liver. The preferred drug treatment and the known complications associated with their use in pregnancy are also described. Where possible, studies relating to the safety of different therapeutic options are discussed.
Williamson
C
C
Wellcome Advanced Clinical Fellow, Imperial College School of Medicine, London, UK.
D000932:Antiemetics / Q000627:therapeutic use; D002779:Cholestasis / Q000188:drug therapy; D004415:Dyspepsia / Q000188:drug therapy; D005260:Female; D005767:Gastrointestinal Diseases / Q000188:drug therapy*; D006525:Hepatitis, Viral, Human / Q000188:drug therapy; D006801:Humans; D006939:Hyperemesis Gravidarum / Q000188:drug therapy; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy; D010437:Peptic Ulcer / Q000188:drug therapy; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy*
D000932:Antiemetics